These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38709233)

  • 1. Spatial transcriptomic analysis reveals local effects of intratumoral fusobacterial infection on DNA damage and immune signaling in rectal cancer.
    Duggan WP; Kisakol B; Woods I; Azimi M; Dussmann H; Fay J; O'Grady T; Maguire B; Reynolds IS; Salvucci M; Slade DJ; McNamara DA; Burke JP; Prehn JHM
    Gut Microbes; 2024; 16(1):2350149. PubMed ID: 38709233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased Fusobacterium tumoural abundance affects immunogenicity in mucinous colorectal cancer and may be associated with improved clinical outcome.
    Duggan WP; Salvucci M; Kisakol B; Lindner AU; Reynolds IS; Dussmann H; Fay J; O'Grady T; Longley DB; Ginty F; Mc Donough E; Slade DJ; Burke JP; Prehn JHM
    J Mol Med (Berl); 2023 Jul; 101(7):829-841. PubMed ID: 37171483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiplexed Immunofluorescence Imaging Reveals an Immune-Rich Tumor Microenvironment in Mucinous Rectal Cancer Characterized by Increased Lymphocyte Infiltration and Enhanced Programmed Cell Death Protein 1 Expression.
    Duggan WP; Kisakol B; O'Connell E; Matveeva A; O'Grady T; McDonough E; Lindner AU; McNamara D; Longley D; Ginty F; Burke JP; Prehn JHM
    Dis Colon Rectum; 2023 Jul; 66(7):914-922. PubMed ID: 36525395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High Expression of VSTM2L Induced Resistance to Chemoradiotherapy in Rectal Cancer through Downstream IL-4 Signaling.
    Liu H; Zhang Z; Zhen P; Zhou M
    J Immunol Res; 2021; 2021():6657012. PubMed ID: 33506057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive Significance of Mucinous Histology on Pathologic Complete Response Rate Following Capecitabine-Based Neoadjuvant Chemoradiation in Rectal Cancer: a Comparative Study.
    Hosseini S; Nguyen N; Mohammadianpanah M; Mirzaei S; Bananzadeh AM
    J Gastrointest Cancer; 2019 Dec; 50(4):716-722. PubMed ID: 29984382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential and longitudinal immune gene patterns associated with reprogrammed microenvironment and viral mimicry in response to neoadjuvant radiotherapy in rectal cancer.
    Wilkins A; Fontana E; Nyamundanda G; Ragulan C; Patil Y; Mansfield D; Kingston J; Errington-Mais F; Bottomley D; von Loga K; Bye H; Carter P; Tinkler-Hundal E; Noshirwani A; Downs J; Dillon M; Demaria S; Sebag-Montefiore D; Harrington K; West N; Melcher A; Sadanandam A
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33678606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of preoperative chemoradiotherapy on the immunological status of rectal cancer patients.
    Yasui K; Kondou R; Iizuka A; Miyata H; Tanaka E; Ashizawa T; Nagashima T; Ohshima K; Urakami K; Kusuhara M; Muramatsu K; Sugino T; Yamguchi K; Mori K; Harada H; Nishimura T; Kagawa H; Yamakawa Y; Hino H; Shiomi A; Akiyama Y
    J Radiat Res; 2020 Sep; 61(5):766-775. PubMed ID: 32672335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucinous adenocarcinoma of the colon and rectum: A genomic analysis.
    Reynolds IS; O'Connell E; Fichtner M; McNamara DA; Kay EW; Prehn JHM; Furney SJ; Burke JP
    J Surg Oncol; 2019 Dec; 120(8):1427-1435. PubMed ID: 31729037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The correlation between immune subtypes and consensus molecular subtypes in colorectal cancer identifies novel tumour microenvironment profiles, with prognostic and therapeutic implications.
    Soldevilla B; Carretero-Puche C; Gomez-Lopez G; Al-Shahrour F; Riesco MC; Gil-Calderon B; Alvarez-Vallina L; Espinosa-Olarte P; Gomez-Esteves G; Rubio-Cuesta B; Sarmentero J; La Salvia A; Garcia-Carbonero R
    Eur J Cancer; 2019 Dec; 123():118-129. PubMed ID: 31678770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Southern Chinese populations harbour non-nucleatum Fusobacteria possessing homologues of the colorectal cancer-associated FadA virulence factor.
    Yeoh YK; Chen Z; Wong MCS; Hui M; Yu J; Ng SC; Sung JJY; Chan FKL; Chan PKS
    Gut; 2020 Nov; 69(11):1998-2007. PubMed ID: 32051205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intratumoral budding and automated CD8-positive T-cell density in pretreatment biopsies can predict response to neoadjuvant therapy in rectal adenocarcinoma.
    Farchoukh L; Hartman DJ; Ma C; Celebrezze J; Medich D; Bahary N; Frank M; Pantanowitz L; Pai RK
    Mod Pathol; 2021 Jan; 34(1):171-183. PubMed ID: 32661298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ca
    Kumar R; Raman R; Kotapalli V; Gowrishankar S; Pyne S; Pollack JR; Bashyam MD
    J Mol Med (Berl); 2018 Feb; 96(2):135-146. PubMed ID: 29124284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural killer-like signature observed post therapy in locally advanced rectal cancer is a determinant of pathological response and improved survival.
    Alderdice M; Dunne PD; Cole AJ; O'Reilly PG; McArt DG; Bingham V; Fuchs MA; McQuaid S; Loughrey MB; Murray GI; Samuel LM; Lawler M; Wilson RH; Salto-Tellez M; Coyle VM
    Mod Pathol; 2017 Sep; 30(9):1287-1298. PubMed ID: 28621318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptomic and immunophenotypic profiling reveals molecular and immunological hallmarks of colorectal cancer tumourigenesis.
    Roelands J; van der Ploeg M; Ijsselsteijn ME; Dang H; Boonstra JJ; Hardwick JCH; Hawinkels LJAC; Morreau H; de Miranda NFCC
    Gut; 2023 Jul; 72(7):1326-1339. PubMed ID: 36442992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integration of single-cell RNA sequencing and bulk RNA transcriptome sequencing reveals a heterogeneous immune landscape and pivotal cell subpopulations associated with colorectal cancer prognosis.
    Zhang Q; Liu Y; Wang X; Zhang C; Hou M; Liu Y
    Front Immunol; 2023; 14():1184167. PubMed ID: 37675100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crosstalk Between the MSI Status and Tumor Microenvironment in Colorectal Cancer.
    Lin A; Zhang J; Luo P
    Front Immunol; 2020; 11():2039. PubMed ID: 32903444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic subtypes predict outcomes in colorectal cancer.
    Kasurinen J; Beilmann-Lehtonen I; Kaprio T; Hagström J; Haglund C; Böckelman C
    Acta Oncol; 2023 Mar; 62(3):245-252. PubMed ID: 36867078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metastatic role of mammalian target of rapamycin signaling activation by chemoradiotherapy in advanced rectal cancer.
    Shiratori H; Kawai K; Okada M; Nozawa H; Hata K; Tanaka T; Nishikawa T; Shuno Y; Sasaki K; Kaneko M; Murono K; Emoto S; Ishii H; Sonoda H; Ushiku T; Ishihara S
    Cancer Sci; 2020 Apr; 111(4):1291-1302. PubMed ID: 31997546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Implications of Mucinous Differentiation in Metastatic Colorectal Carcinoma Can Be Explained by Distinct Molecular and Clinicopathologic Characteristics.
    Khan M; Loree JM; Advani SM; Ning J; Li W; Pereira AAL; Lam M; Raghav K; Morris VK; Broaddus R; Maru D; Overman MJ; Kopetz S
    Clin Colorectal Cancer; 2018 Dec; 17(4):e699-e709. PubMed ID: 30205948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. JAK/STAT/SOCS-signaling pathway and colon and rectal cancer.
    Slattery ML; Lundgreen A; Kadlubar SA; Bondurant KL; Wolff RK
    Mol Carcinog; 2013 Feb; 52(2):155-66. PubMed ID: 22121102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.